<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03540290</url>
  </required_header>
  <id_info>
    <org_study_id>PER-ECL-2017-01</org_study_id>
    <nct_id>NCT03540290</nct_id>
  </id_info>
  <brief_title>Treatment of Peri-implant Mucositis by Means of Implant Decontamination and Modification of the Implant Supported-prosthesis</brief_title>
  <official_title>Treatment of Peri-implant Mucositis by Means of Implant Decontamination and Modification of the Implant Supported-prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitat Internacional de Catalunya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitat Internacional de Catalunya</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test the modification of the implant prosthesis, in order to facilitate access to biofilm&#xD;
      control, in combination with decontamination of the implant surface by means of an ultrasonic&#xD;
      device with a plastic tip and plastic curettes, in comparison with the decontamination of the&#xD;
      implant surface by means of an ultrasonic device with a plastic tip and plastic curettes, and&#xD;
      no modification of the implant prosthesis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 10, 2017</start_date>
  <completion_date type="Anticipated">June 20, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 12, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate modified sulcus Bleeding Index changes at 3 and 6 months, by the modification of the implant prosthesis in order to facilitate oral hygiene, hygiene instructions and surface decontamination</measure>
    <time_frame>1, 3 and 6 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Peri-implant Mucositis</condition>
  <arm_group>
    <arm_group_label>Mechanical instrumentation and oral hygiene instructions</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Modification of the implant supported prostheses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Modification of the implant supported prostheses in order to facilitate oral hygiene</intervention_name>
    <description>Peri-implant mucositis will be treated by individualized oral hygiene instructions and decontamination of the implant surface by ultrasonic device with a plastic tip and plastic curettes plus the modification of the implant prosthesis in order to facilitate oral hygiene access</description>
    <arm_group_label>Mechanical instrumentation and oral hygiene instructions</arm_group_label>
    <arm_group_label>Modification of the implant supported prostheses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  (1) Presence of, at least, one titanium implant exhibiting peri-implant mucositis,&#xD;
             defined as bleeding on gentle probing (0.15 N) in at least one peri-implant site.&#xD;
&#xD;
             (2) No signs of loss of supporting bone after initial bone remodelling. In cases where&#xD;
             baseline radiograph is available, it will be used for comparison, otherwise a maximum&#xD;
             of 2 mm of crestal bone loss will be accepted (5).&#xD;
&#xD;
             (3) Single tooth and bridgework restoration with an inappropriate prosthesis design or&#xD;
             contour which difficult oral hygiene access (overcontoured prosthesis, prostheses&#xD;
             presenting closed embrasures, an abrupt emergence profile or excessive buccal&#xD;
             flanges).&#xD;
&#xD;
             (4) Presence of &gt;1 mm of keratinized peri-implant mucosa.&#xD;
&#xD;
             (5) A good level of oral hygiene, defined as an O'Leary et al. plaque index &lt;25% (16).&#xD;
&#xD;
             (6) Absence of systemic diseases that could influence the outcome of the therapy (i.e.&#xD;
             controlled diabetes, with HbA1c&lt;7, patients will be included).&#xD;
&#xD;
             (7) Non-smoker or light smoking status in smokers (&lt;10 cigarettes/day).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  (1) Untreated periodontal conditions.&#xD;
&#xD;
             (2) Pregnant or lactating women.&#xD;
&#xD;
             (3) Patients who received systemic antibiotics in the last 3 months.&#xD;
&#xD;
             (4) Patients who received treatment of PM in the past 3 months.&#xD;
&#xD;
             (5) Patients receiving corticoids or medications known to have effect on gingival&#xD;
             growth i.e. calcium channel antagonists, immunosuppressants or antiepileptic drugs.&#xD;
&#xD;
        In those cases diagnosed with peri-implantitis, individualized treatment will be provided,&#xD;
        apart from the present study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Beatriz de Tapia</last_name>
    <phone>0034 646486084</phone>
    <email>beatrizdetapia@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitat Internacional de Catalunya</name>
      <address>
        <city>Barcelona</city>
        <state>Sant Cugat Del Vall√®s</state>
        <zip>08195</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beatriz de Tapia</last_name>
      <phone>0034646486084</phone>
      <email>beatrizdetapia@gmail.com</email>
    </contact>
    <contact_backup>
      <phone>0034646486084</phone>
      <email>beatrizdetapia@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>April 27, 2018</study_first_submitted>
  <study_first_submitted_qc>May 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2018</study_first_posted>
  <last_update_submitted>October 22, 2018</last_update_submitted>
  <last_update_submitted_qc>October 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitat Internacional de Catalunya</investigator_affiliation>
    <investigator_full_name>Beatriz de Tapia</investigator_full_name>
    <investigator_title>Clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mucositis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>The results obtained are expected to be published in both national and international journals. In addition, the results will be disseminated national and international scientific events.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

